Basecamp Research secures $140 million in funding to enhance its AI-driven drug design capabilities. This investment highlights the increasing interest in AI technologies within the biotech sector, following similar funding rounds for companies like Isomorphic Labs and Enveda.
Basecamp Research joins the growing group of AI-forward biotechs that in recent months have brought in notable sums from investors, including Isomorphic Labs and Enveda.
Original title: “Backed by NVIDIA, Basecamp bags $140M to advance AI-designed drugs”